首页> 外国专利> RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY

RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY

机译:放射疗法增强化疗药物的大分子输送

摘要

Described herein are anti-cancer compounds composed of a macromolecule comprising (1) at least one anti-cancer agent directly or indirectly bonded to the macromolecule and (2) at least one high Z element directly or indirectly bonded to the macromolecule that is capable of producing Auger electrons upon exposure to X-ray energy. When the compounds are exposed to low energy X-ray (e.g., kilo electron volts KeV) Auger electrons are produced by the high Z elements present in the compound. Because lower energy is required when compared to typical radiotherapy, which uses therapeutic X-ray energy in the million electron volt range (MeV), the subject experiences lower collateral damage when compared to radiation therapy. Additionally, the presence of the anti-cancer agent provides a second mechanism for killing cancer cells. Methods for making and using the anti-cancer compounds are also described herein.
机译:本文描述的是由大分子组成的抗癌化合物,所述大分子包含(1)至少一种直接或间接键合于大分子的抗癌剂和(2)至少一种直接或间接键合于大分子的高Z元素,其能够在暴露于X射线能量时产生俄歇电子。当化合物暴露于低能X射线(例如千电子伏特KeV)时,化合物中存在的高Z元素会产生俄歇电子。由于与使用百万电子伏特范围(MeV)的X射线治疗能量的典型放射疗法相比,所需能量更低,因此与放射疗法相比,受试者遭受的附带损害更少。另外,抗癌剂的存在提供了杀死癌细胞的第二种机制。本文还描述了制备和使用抗癌化合物的方法。

著录项

  • 公开/公告号US2016166693A1

    专利类型

  • 公开/公告日2016-06-16

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF UTAH RESEARCH FOUNDATION;

    申请/专利号US201615049198

  • 发明设计人 HAMID GHANDEHARI;ABHIJIT RAY;

    申请日2016-02-22

  • 分类号A61K41;C07F15;A61K47/48;A61N5/10;A61K31/704;A61K31/4745;A61K33/24;C07H23;A61K31/337;

  • 国家 US

  • 入库时间 2022-08-21 14:38:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号